Follow
Sarah Stanley
Sarah Stanley
Verified email at berkeley.edu
Title
Cited by
Cited by
Year
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system
SA Stanley, S Raghavan, WW Hwang, JS Cox
Proceedings of the National Academy of Sciences 100 (22), 13001-13006, 2003
7152003
The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis
SA Stanley, JE Johndrow, P Manzanillo, JS Cox
The Journal of Immunology 178 (5), 3143-3152, 2007
5012007
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
SA Stanley, SS Grant, T Kawate, N Iwase, M Shimizu, C Wivagg, M Silvis, ...
ACS chemical biology 7 (8), 1377-1384, 2012
3012012
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
SA Stanley, AK Barczak, MR Silvis, SS Luo, K Sogi, M Vokes, MA Bray, ...
PLoS pathogens 10 (2), e1003946, 2014
2742014
C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis
PADG Champion, SA Stanley, MM Champion, EJ Brown, JS Cox
Science 313 (5793), 1632-1636, 2006
2692006
A non‐RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis
JA MacGurn, S Raghavan, SA Stanley, JS Cox
Molecular microbiology 57 (6), 1653-1663, 2005
2382005
HIF-1α is an essential mediator of IFN-γ–dependent immunity to Mycobacterium tuberculosis
J Braverman, KM Sogi, D Benjamin, DK Nomura, SA Stanley
The Journal of Immunology 197 (4), 1287-1297, 2016
2212016
Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense
M Knight, J Braverman, K Asfaha, K Gronert, S Stanley
PLoS pathogens 14 (1), e1006874, 2018
1922018
Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1α and repression of NF-κB
J Braverman, SA Stanley
The Journal of Immunology 199 (5), 1805-1816, 2017
1362017
Host–Pathogen Interactions During Mycobacterium tuberculosis infections
SA Stanley, JS Cox
Pathogenesis of Mycobacterium tuberculosis and its interaction with the host …, 2013
1332013
RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities
AK Barczak, JE Gomez, BB Kaufmann, ER Hinson, L Cosimi, ...
Proceedings of the national academy of sciences 109 (16), 6217-6222, 2012
1252012
Stereocontrol in intermolecular dirhodium (II)-catalyzed carbonyl ylide formation and reactions. Dioxolanes and dihydrofurans
MP Doyle, DC Forbes, MN Protopopova, SA Stanley, MM Vasbinder, ...
The Journal of Organic Chemistry 62 (21), 7210-7215, 1997
1221997
SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
A Jack, LS Ferro, MJ Trnka, E Wehri, A Nadgir, X Nguyenla, D Fox, ...
PLoS biology 19 (10), e3001425, 2021
1142021
T cell-intrinsic requirement for NF-κB induction in postdifferentiation IFN-γ production and clonal expansion in a Th1 response
RA Corn, MA Aronica, F Zhang, Y Tong, SA Stanley, SRA Kim, ...
The Journal of Immunology 171 (4), 1816-1824, 2003
1142003
STING-activating adjuvants elicit a Th17 immune response and protect against Mycobacterium tuberculosis infection
E Van Dis, KM Sogi, CS Rae, KE Sivick, NH Surh, ML Leong, DB Kanne, ...
Cell reports 23 (5), 1435-1447, 2018
1112018
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
SA Stanley, T Kawate, N Iwase, M Shimizu, AE Clatworthy, ...
Proceedings of the National Academy of Sciences 110 (28), 11565-11570, 2013
1092013
The Innate Immune Response to Mycobacterium tuberculosis Infection
MM Ravesloot-Chávez, E Van Dis, SA Stanley
Annual review of immunology 39, 611-637, 2021
972021
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model
SS Grant, T Kawate, PP Nag, MR Silvis, K Gordon, SA Stanley, ...
ACS chemical biology 8 (10), 2224-2234, 2013
872013
Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32
T Kawate, N Iwase, M Shimizu, SA Stanley, S Wellington, E Kazyanskaya, ...
Bioorganic & medicinal chemistry letters 23 (22), 6052-6059, 2013
812013
Enantiocontrolled macrocycle formation by catalytic intramolecular cyclopropanation
MP Doyle, W Hu, B Chapman, AB Marnett, CS Peterson, JP Vitale, ...
Journal of the American Chemical Society 122 (24), 5718-5728, 2000
802000
The system can't perform the operation now. Try again later.
Articles 1–20